---
$id: https://graph.org.ai/products/commodity/51391740
$type: Product
source: UNSPSC
code: "51391740"
title: "Tazolol"
class: "51391700"
classTitle: "Sympathomimetic or adrenergic amino alcohols"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tazolol

**UNSPSC Code**: 51391740
**Class**: [Sympathomimetic or adrenergic amino alcohols](Sympathomimetic or adrenergic amino alcohols.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17B9PXO2SW. European Medicines Agency schedules Tobuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11135MIG. Tobuterol generally arises in the molecular formula C28H31NO5. The term TOBUTEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, no. 5 1981, list 21.) TOBUTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tazolol under HS 29341000 and SITC 51579. As of Q4 2014, TAZOLOL remains the US FDA Preferred Term for this commodity. Tazolol bears US NLM identifiers UMLS ID C0075871 and NCI Concept Code C81660. SMILES: OC(CNC(C)(C)C)C1CC(OC(=O)C2CCC(CC2)C)CC(OC(=O)C2CCC(CC2)C)C1.

